Healthcare IoT Security 2020
Great Options in an Emerging Market (A Decision Insights Report)

Author
Joe VanDeGraaff

Author
Dan Czech

November 9, 2020 | Read Time: 18 minutes

Adoption of security solutions for the healthcare internet of things (IoT) continues to grow as healthcare organizations look for ways to understand and manage the risk associated with connected devices. In most deployments, the focus has shifted from securing mainly medical devices to covering both medical devices and the broader IoT devices found in healthcare settings. As the market matures, organizations are also beginning to look beyond core capabilities—where most solutions are comparable—to factors like cost, ROI, expertise, and vendor culture when making buying decisions. With many strong options in the market, the bar for vendors is high. KLAS spoke with 51 healthcare organizations to understand which vendors are being selected and why and to glean early insights into customer satisfaction.

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Key Findings:

Medigate, Ordr Emerge as Leaders in Growing Healthcare IoT Market
Palo Alto Acquisition of Zingbox Creates Uncertainty
Concerns about Armis' Technology Abilities Driven by Sales Team; New Entrant Cylera Makes a Dent with Strong Healthcare Team and Relationships
Asimily and Up-and-Coming Sensato Leverage Healthcare Expertise for Early Traction
CyberMDX and Cynerio See Overall Slow Market Traction
Top Considered Vendors at a Glance
About This Report

Writer
Amanda Wind Smith

Designer
Madison Fujimoto

Project Manager
Isaac Burgi

Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.